SCM
EW icon

Sigma Capital Management’s Edwards Lifesciences EW Stock Holding History

Sigma Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-60,000
Closed -$696K – 194
2013
Q3 		$696K Buy
+60,000
New +$702K 0.03% 245

Other funds holding EW

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sigma Capital Management's EW Position: Q4 2013 in Review

Sigma Capital Management sold out of Edwards Lifesciences (EW) in Q4 2013, closing a stake of 60,000 shares — an estimated $696K sold.

Sigma Capital Management first reported a position in EW in Q3 2013 and held it in 1 quarter. The position peaked at $696K in Q3 2013. 407 funds tracked by Wall St. Rank hold EW as of Q4 2013.

  • Sigma Capital Management reported no remaining Edwards Lifesciences position as of Q4 2013 after selling out during the quarter.
  • Sigma Capital Management sold 60,000 Edwards Lifesciences shares in Q4 2013, an estimated $696K.
  • Sigma Capital Management first reported a position in Edwards Lifesciences in Q3 2013 and held it in 1 quarter.
  • Sigma Capital Management's Edwards Lifesciences position peaked at $696K in Q3 2013.
  • 407 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2013.

Based on Sigma Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.